Patents by Inventor Johnathan D. Ebben

Johnathan D. Ebben has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide inhibitors of telomerase translocation and therapeutic uses thereof
    Patent number: 10858397
    Abstract: This disclosure provides compositions and methods for treating or preventing cardiac or vascular toxicity in a subject receiving a chemotherapeutic agent, where the cardiac or vascular toxicity is associated with administration of the chemotherapeutic agent. Also provided are compositions and methods for treating or preventing endothelial dysfunction and for modulating endothelial function and oxidative stress.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: December 8, 2020
    Assignee: The Medical College of Wisconsin, Inc.
    Inventors: Johnathan D. Ebben, Andreas M. Beyer
  • Peptide Inhibitors of Telomerase Translocation and Therapeutic Uses Thereof
    Publication number: 20180251491
    Abstract: This disclosure provides compositions and methods for treating or preventing cardiac or vascular toxicity in a subject receiving a chemotherapeutic agent, where the cardiac or vascular toxicity is associated with administration of the chemotherapeutic agent. Also provided are compositions and methods for treating or preventing endothelial dysfunction and for modulating endothelial function and oxidative stress.
    Type: Application
    Filed: August 26, 2016
    Publication date: September 6, 2018
    Inventors: Johnathan D. Ebben, Andreas M. Beyer